A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Top House Republican Demands SEC Turn Over Documents on ESG
Enbridge Is Building Gas Powerhouse by Buying Dominion Utilities
Chipmaker Wolfspeed secures $1.25 billion in debt funding led by Apollo Global
Global ESG Market Shrinks After Sizable Drop in US
EU looks to take lead in metaverse world, avoid Big Tech dominance
Finance Teams Are Alarmingly Less Efficient Than a Year Ago, According to New Research from insightsoftware
Kingston Digital Expands External SSD Lineup
Nvidia Stock Is Falling. Here’s Why It Just Can’t Break the $500 Level.